Avita Medical | 1811094D - Operating Profit

Stock Price
1.09
Daily Change
-0.02 -1.80%
Monthly
4.31%
Yearly
-62.67%
Q1 Forecast
1.19

Avita Medical reported AUD-11.15M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Celltrion KRW 301.04B 58.57B Sep/2025
Clinuvel Pharmaceuticals AUD 39.05M 21.49M Jun/2024
Cochlear AUD 125.55M 149.05M Jun/2025
CSL USD 666M 1.31B Jun/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.75B 1.58B Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 400K Dec/2024
Mayne Pharma AUD -3.3M 15.67M Jun/2024
Medical Developments International AUD -480K 662K Jun/2025
Nanosonics AUD 5.3M 3.4M Jun/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Organigram Holdings CAD -28.05M 7.76M Sep/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
Pharma Mar EUR -3.96M 28.06M Sep/2025
Polynovo AUD 513K 902K Jun/2024
PYC Therapeutics AUD -13.47M 12.42M Jun/2025
Qiagen NV USD 137.29M 1.32M Sep/2025
Ramsay Health Care AUD 537.2M 337.2M Jun/2025
ResMed USD 500.3M 37.95M Dec/2025
Sartorius EUR 150.1M 11.7M Sep/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Telix Pharmaceuticals AUD 17.72M 24.27M Dec/2024
Tilray USD -20.01M 9.34M Sep/2025
Zz Pientze Pharmaceu CNY 501.33M 52.54M Sep/2025